Reproducibility of locus coeruleus and substantia nigra imaging with neuromelanin sensitive MRI.

PubWeight™: 0.77^‹?›

🔗 View Article (PMID 27687624)

Published in MAGMA on September 29, 2016

Authors

Jason Langley¹^,2, Daniel E Huddleston³, Christine J Liu⁴, Xiaoping Hu⁵^,6

Author Affiliations

1: Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA.
2: Center for Advanced Neuroimaging, University of California, Riverside, Riverside, CA, USA.
3: Department of Neurology, Emory University, Atlanta, GA, USA.
4: The Westminster Schools, Atlanta, GA, USA.
5: Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA. xhu@engr.ucr.edu.
6: Department of Bioengineering, University of California, Riverside, Materials Science and Engineering 205, Riverside, CA, USA. xhu@engr.ucr.edu.

Articles citing this ↘

In vivo detection of lateral-ventral tier nigral degeneration in Parkinson's disease. Hum Brain Mapp (2017) 0.76

In vivo visualization of the locus coeruleus in humans: quantifying the test-retest reliability. Brain Struct Funct (2017) 0.75

Articles cited by this ↗

The measurement of observer agreement for categorical data. Biometrics (1977) 216.56

Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging (2002) 22.40

Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol (2011) 3.69

Disease-specific patterns of locus coeruleus cell loss. Ann Neurol (1992) 1.64

Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease. Neuroreport (2006) 1.37

Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes. J Neurochem (2001) 1.33

T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease. Mov Disord (2011) 1.14

Image analyser-assisted morphometry of the locus coeruleus in Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis. Brain (1995) 1.05

Locus coeruleus cell loss in the aging human brain: a non-random process. J Comp Neurol (1995) 0.98

Visualization of neuromelanin in the Substantia nigra and locus ceruleus at 1.5T using a 3D-gradient echo sequence with magnetization transfer contrast. Magn Reson Med Sci (2008) 0.97

3D neuromelanin-sensitive magnetic resonance imaging with semi-automated volume measurement of the substantia nigra pars compacta for diagnosis of Parkinson's disease. Neuroradiology (2013) 0.90

Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson's disease using neuromelanin-sensitive MR imaging. Neurosci Lett (2013) 0.86

Simultaneous imaging of locus coeruleus and substantia nigra with a quantitative neuromelanin MRI approach. Magn Reson Imaging (2014) 0.84

A multicontrast approach for comprehensive imaging of substantia nigra. Neuroimage (2015) 0.84

Automated neuromelanin imaging as a diagnostic biomarker for Parkinson's disease. Mov Disord (2015) 0.83

Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients. Eur J Neurol (2014) 0.80

High-resolution quantitative imaging of the substantia nigra. Conf Proc IEEE Eng Med Biol Soc (2015) 0.77

Articles by these authors ⇆

Improved Neuroimaging Atlas of the Dentate Nucleus. Cerebellum (2017) 0.75